Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

The role of fibroblast growth factor-23 in cardiorenal syndrome.

Kovesdy CP, Quarles LD.

Nephron Clin Pract. 2013;123(3-4):194-201. doi: 10.1159/000353593. Epub 2013 Aug 6. Review.

2.

Fibroblast growth factor-23: what we know, what we don't know, and what we need to know.

Kovesdy CP, Quarles LD.

Nephrol Dial Transplant. 2013 Sep;28(9):2228-36. doi: 10.1093/ndt/gft065. Epub 2013 Apr 25. Review.

3.

Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.

Leifheit-Nestler M, Große Siemer R, Flasbart K, Richter B, Kirchhoff F, Ziegler WH, Klintschar M, Becker JU, Erbersdobler A, Aufricht C, Seeman T, Fischer DC, Faul C, Haffner D.

Nephrol Dial Transplant. 2016 Jul;31(7):1088-99. doi: 10.1093/ndt/gfv421. Epub 2015 Dec 17.

PMID:
26681731
4.

FGF23 from bench to bedside.

Kovesdy CP, Quarles LD.

Am J Physiol Renal Physiol. 2016 Jun 1;310(11):F1168-74. doi: 10.1152/ajprenal.00606.2015. Epub 2016 Feb 10. Review.

5.

Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.

Quarles LD.

Exp Cell Res. 2012 May 15;318(9):1040-8. doi: 10.1016/j.yexcr.2012.02.027. Epub 2012 Mar 7. Review.

6.

Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats.

Leifheit-Nestler M, Grabner A, Hermann L, Richter B, Schmitz K, Fischer DC, Yanucil C, Faul C, Haffner D.

Nephrol Dial Transplant. 2017 Sep 1;32(9):1493-1503. doi: 10.1093/ndt/gfw454.

PMID:
28339837
7.

The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.

Tranæus Lindblad Y, Olauson H, Vavilis G, Hammar U, Herthelius M, Axelsson J, Bárány P.

Pediatr Nephrol. 2018 Jan;33(1):147-157. doi: 10.1007/s00467-017-3766-5. Epub 2017 Aug 9.

8.

[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].

Komaba H.

Clin Calcium. 2010 Jul;20(7):1028-36. doi: CliCa100710281036. Review. Japanese.

PMID:
20585181
9.

FGF23 induces left ventricular hypertrophy.

Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M.

J Clin Invest. 2011 Nov;121(11):4393-408. doi: 10.1172/JCI46122. Epub 2011 Oct 10.

10.

Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.

Koizumi M, Komaba H, Fukagawa M.

Contrib Nephrol. 2013;180:110-23. doi: 10.1159/000346791. Epub 2013 May 3. Review.

PMID:
23652554
11.

Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?

Evenepoel P, Rodriguez M, Ketteler M.

Semin Nephrol. 2014 Mar;34(2):151-63. doi: 10.1016/j.semnephrol.2014.02.007. Epub 2014 Feb 18. Review.

PMID:
24780470
12.

The role of FGF23 in CKD--with or without Klotho.

Komaba H, Fukagawa M.

Nat Rev Nephrol. 2012 Jun 19;8(8):484-90. doi: 10.1038/nrneph.2012.116. Review.

PMID:
22714041
13.

Klotho/FGF23 Axis in CKD.

Tsuchiya K, Nagano N, Nitta K.

Contrib Nephrol. 2015;185:56-65. doi: 10.1159/000380970. Epub 2015 May 19. Review.

PMID:
26023015
14.

New insights into the FGF23-Klotho axis.

Olauson H, Vervloet MG, Cozzolino M, Massy ZA, Ureña Torres P, Larsson TE.

Semin Nephrol. 2014 Nov;34(6):586-97. doi: 10.1016/j.semnephrol.2014.09.005. Review.

PMID:
25498378
15.

Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.

Tanaka S, Fujita S, Kizawa S, Morita H, Ishizaka N.

PLoS One. 2016 Jul 11;11(7):e0156860. doi: 10.1371/journal.pone.0156860. eCollection 2016.

16.

A short story of Klotho and FGF23: a deuce of dark side or the savior?

Ersoy FF.

Int Urol Nephrol. 2014 Mar;46(3):577-81. doi: 10.1007/s11255-013-0536-6. Epub 2013 Sep 21. Review.

PMID:
24057685
17.

Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.

Xie J, Yoon J, An SW, Kuro-o M, Huang CL.

J Am Soc Nephrol. 2015 May;26(5):1150-60. doi: 10.1681/ASN.2014040325. Epub 2014 Dec 4.

18.

Update on fibroblast growth factor 23 in chronic kidney disease.

Wolf M.

Kidney Int. 2012 Oct;82(7):737-47. doi: 10.1038/ki.2012.176. Epub 2012 May 23. Review.

19.

FGF23 and Klotho in chronic kidney disease.

Olauson H, Larsson TE.

Curr Opin Nephrol Hypertens. 2013 Jul;22(4):397-404. doi: 10.1097/MNH.0b013e32836213ee. Review.

PMID:
23666415
20.

Fibroblast growth factor 23/klotho axis in chronic kidney disease.

Nitta K, Nagano N, Tsuchiya K.

Nephron Clin Pract. 2014;128(1-2):1-10. doi: 10.1159/000365787. Epub 2014 Nov 8. Review.

Supplemental Content

Support Center